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ABSTRACT
Objective: To estimate the frequency of depression/anxiety and to establish the social, 
epilepsy and psychiatric characteristics in individuals with epilepsy. Method: A cross-
sectional study was employed to evaluate 153 subjects with epilepsy who were identified in 
a previous community-based survey. First, a structured interview was conducted, followed 
by a psychiatric evaluation. Subjects with depression were compared to those without, 
and subjects with anxiety were compared to those without. Results: The prevalence of 
anxiety and depression was 39.4 and 24.4%, respectively. Both were associated with low 
schooling (OR 3.8, 95% CI 1.6 to 9.0 and OR 2.8, 95% CI 1.2 to 6.5 for depression and 
anxiety, respectively), lifetime suicidal thoughts (OR 4.4, 95% CI 1.9 to 10.3 and OR 3.6, 
95% CI 1.7 to 7.7) and lifetime suicide attempts (OR 9.3, 95% CI 2.6 to 32.8 and OR 6.9, 
95% CI 1.8 to 26.4). Conclusion: The high rates of depression and anxiety reinforced the 
need for recognition and treatment of mental disorders in epilepsy. 
Key words: mood disorders, anxiety, depression, epilepsy, epidemiology, suicide attempt. 
Depressão e ansiedade na epilepsia: uma amostra da comunidade no Brasil
RESUMO
Objetivo: Estimar a frequência de depressão/ansiedade em pessoas com epilepsia e 
estabelecer as características sociais, da epilepsia e psiquiátricas associadas. Método: 
Foi feito um estudo transversal para avaliar 153 sujeitos com epilepsia identificados 
em um levantamento prévio feito na comunidade. Primeiramente foi realizada uma 
entrevista estruturada, seguida de uma avaliação psiquiátrica. Os sujeitos deprimidos 
foram comparados com aqueles sem depressão e os sujeitos com ansiedade foram 
comparados com aqueles sem ela. Resultados: A prevalência de ansiedade e depressão 
foi de 39,4% e 24,4%, respectivamente. Ambas foram associadas a baixa escolaridade (OR 
3,8; IC95% 1,6-9,0 e OR 2,8, IC95% 1,2- 6,5 para depressão e ansiedade, respectivamente), 
ideação suicida (OR 4,4; IC95% 1,9-10,3 e OR 3,6; IC95% 1,7-7,7) e tentativa de suicídio 
(OR 9,3; IC95% 2,6-32,8 e OR 6,9; IC95% 1,8-26,4). Conclusão: As altas taxas de depressão 
e ansiedade reforçam a necessidade de reconhecimento e tratamento dos transtornos 
mentais na epilepsia. 
Palavras-chave: transtornos do humor, ansiedade, depressão, epilepsia, epidemiologia, 
tentativa de suicídio. 
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It is becoming increasingly accepted 
that psychological disorders have a broad 
impact on individuals with epilepsy. Non-
selected populations of people with epi-
lepsy present consistently higher rates 
of psychiatric comorbidity compared to 
the general population1-3. Depression 
and anxiety disorders are the most fre-
quent psychiatric comorbidities in epi-
lepsy2-4. The lifetime prevalence of depres-
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sive disorder in epilepsy is unclear, varying from 8-48% 
depending on the methodological approach4,5. In a Ca-
nadian population-based study, the life prevalence for 
anxiety and depressive disorders in people with epilepsy 
was 22.8% and 17.4%, respectively3. 
Depression in epilepsy has been associated with poor 
quality of life6,7, suicidal behavior8, poor seizure control9, 
unemployment9, presence of another chronic health con-
dition9, perception of stigma10 and effect of antiepileptic 
medication9. Although anxiety disorders have received less 
attention than mood disorders in patients with epilepsy, 
they have been associated with poor quality of life,11 lack 
of seizure control1,10,12 and earlier age onset of epilepsy1. 
Despite the impact and link of psychiatric disorders with 
epilepsy, they are all underrecognized and undertreated4,7. 
Especially in developing countries, there is a lack of 
community studies regarding depression and anxiety in 
people with epilepsy. The objectives of this study were to 
estimate the frequencies of depression and anxiety and 
determine the social, epilepsy and psychiatric character-
istics related with these disorders in people with epilepsy 
in a community sample in Brazil. 
METHOD
Study design and setting
This was a cross-sectional study undertaken in 
Campinas, a city with 1.1 million inhabitants in the 
southeast of Brazil. The study was carried out at the dis-
trict of Barão Geraldo, which has approximately 44,000 
inhabitants. This area is comprised of 19 neighborhoods, 
a technological center and two universities. In contrast, 
in the same region, there are rural areas and neighbor-
hoods characterized by low income. 
Subjects
The data were collected between May 2006 and De-
cember 2007. An attempt was made to interview all 171 
individuals who were 13 years or older and had been diag-
nosed with epilepsy in a previous community-based study 
(part of the Global Campaign Against Epilepsy, launched 
by the World Health Organization (WHO), the Interna-
tional League Against Epilepsy and the International Bu-
reau for Epilepsy). In this study, the targeted population 
was surveyed door-to-door and screened or epilepsy, 
and suspected cases were confirmed by neurologists13. 
Instruments
The questionnaire used in this survey was based on 
the WHO Multisite Intervention Study on Suicidal Be-
havior. This survey covers a series of socio-demographic, 
psychosocial and clinical variables. The following psy-
chometric scales, each already validated in Brazil, were 
also included in the study.
The Hospital Anxiety and Depression Scale (HAD) 
covers psychological symptoms of anxiety and depres-
sion. This scale is comprised of 14 multiple-choice items 
regarding anxiety and depression. The cut-off points that 
were adopted for anxiety and depression were at eight 
and seven items positive (out of 14), respectively, as sug-
gested by the Brazilian validation study14. These cut-off 
points provided 74% sensitivity as well as specificity for 
the anxiety parameter. For depression, the sensitivity and 
specificity were 85.7% and 72.4%, respectively14. 
The Global Assessment Scale (GAS) assesses the in-
dividual’s general level of functioning. The evaluation 
was made by the interviewer. The scale ranges from 1 
(the hypothetically sickest person) to 100 (the hypo-
thetically healthiest person)15,16. Subjects with scores 
ranging from 0 to 30 were classified as severe cases, 
scores ranging from 31 to 60 were classified as moderate 
cases and scores ranging from 61 to 100 were classified 
as mild/normal.
The Mini International Neuropsychiatry Interview 
(MINI) version 5.0.0 was used to provide diagnoses 
according to the Diagnostic and Statistical Manual of 
Mental Disorders - Fourth Edition (DSM-IV) criteria17. 
The MINI is a structured diagnostic interview that is 
compatible with the DSM-III-R/IV and ICD-10 criteria17.
First, individuals were approached at their places of 
residence. A short-term interview with the HAD (read out 
for every patient) and the GAS were completed on that oc-
casion. Second, for those who agreed, a new interview was 
scheduled at the university hospital. In this second inter-
view, a detailed psychiatric evaluation, including the MINI, 
was performed by a trained psychiatrist. The first inter-
view was conducted by seven trained interviewers: two 
psychology students, one medical student, two psychol-
ogists and two primary health care workers. The training 
of the interviewers included three 90-minute meetings 
and a pilot with questionnaire application. Meetings at 
regular intervals were held during the data gathering to 
ensure accurate classification of the subjects. No inter-
rater reliability calculation was performed for this data.
Definition of variables 
Active epilepsy – Any patient who has had recurrent 
unprovoked seizures with an interval of 24 h or more in 
the previous 24 months. 
Inactive epilepsy – Any patient who has had recur-
rent unprovoked seizures with an interval between them 
of 24 h or more, but who has been seizure-free for the 
previous 24 months. Both active and inactive epilepsy 
were classified in accordance with previous study13. 
Economic group – Sefined by the presence and 
number of various household items, weighted as per the 
Brazilian Association of Research Companies (ABEP)18. 
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This index of economic classification is based on the 
power of consumption, a measure of personal material 
wealth18. Three groups were defined: low (0-13), middle-
low (14-22) and middle-high / high (23-35). People in the 
low economic group did not have a car or a freezer, 69% 
of them had no electronic appliances, such as a video or 
DVD, and 59% did not possess a refrigerator. 
Occupational status – Was categorized in active 
(full, part-time or temporary employment or student), 
inactive (retired, unemployed or never had a job) and 
homemaker.
Statistical analysis
Subjects were classified as cases and non-cases of 
depressive and anxiety disorders based on their HAD 
scores. The independent variables in the analysis in-
cluded socio-demographic, psychosocial and clinical 
variables and questions about suicidal behavior. Logistic 
regression analysis was used to compare those cases 
and non-cases of depressive and anxiety disorders using 
crude odds ratios (ORs) and 95% confidence intervals 
(CIs). All analyses were conducted using STATA version 
8.0 (StataCorp, College Station, TX, USA). 
Table 1. Demographic, social, occupational and economic characteristics of people with epilepsy who were depressed (n=32), not 




OR† 95% CI‡ P value
Yes No
OR† 95% CI‡ P valueN % N % N % N %
Sex 0.7 0.01
  Male 17 53.1 49 49.5 1.0 18 36.0 45 58.4 1.0
  Female 15 46.9 50 50.5 0.9 0.4-1.9 32 64.0 32 41.6 2.5 1.2-5.2
  Total 32 100 99 100 50 100 77 100
Age bracket <0.0001 0.6
  13-41 8 25 61 61.6 1.0 27 54 38 49.4 1.0
  42 + 24 75 38 38.4 4.8 2.0-11.8 23 46 39 50.6 0.8 0.4-1.7
  Total 32 100 99 100 50 100 77 100
Schooling (years) 0.002 0.02
  ≥4 18 56.3 82 82.8 1.0 33 66.0 65 84.4 1.0
  0<4 14 43.7 17 17.2 3.8 1.6-9.0 17 34.0 12 15.6 2.8 1.2-6.5
  Total 32 100 99 100 50 100 77 100
Marital status 0.04 0.9
  Married / Steady
  relationship
17 53.1 47 47.5 1.0 26 52.0 37 48.0 1.0
  Single 9 28.1 46 46.4 0.5 0.2-1.3 19 38.0 33 42.9 0.8 0.4-1.7
  Separated / 
  Divorced / Widow
6 18.8 6 6.1 2.8 0.8-9.7 5 10.0 7 9.1 1.0 0.3-3.6
  Total 32 100 99 100 50 100 77 100
Occupation 0.006 0.3
  Active§ 10 32.3 59 63.4 1.0 25 52.1 43 58.9 1.0
  Housewife 4 12.9 10 10.8 2.4 0.6-9.0 8 16.7 6 8.2 2.3 0.7-7.4
  Inactive¶ 17 54.8 24 25.8 4.9 1.7-10.4 15 31.2 24 32.9 1.1 0.5-2.4
  Total 31 100 93 100 48 100 73 100
Economic group 0.2 0.05
  Mid-high 23-35 3 10.0 24 24.2 1.0 5 10.4 21 27.3 1.0
  Mid-low 14-22 19 63.3 59 59.6 2.6 0.7-9.5 30 62.5 44 57.1 2.9 1.0-8.4
  Low 0-13 8 26.7 16 16.2 4.0 0.9-17.4 13 27.1 12 15.6 4.5 1.3-15.9
  Total 30 100 99 100 48 100 77 100
†OR: crude odds ratio; ‡95% CI: 95% confidence interval; §Includes students; ¶Retired, unemployed or never had a job.
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Ethical aspects
The study was approved by the university’s ethics 
committee (Comitê de Ética da Faculdade de Ciências 
Médicas da Universidade Estadual de Campinas). All 
subjects enrolled in the research agreed to participate 
and signed a consent form. 
RESULTS
From the 171 individuals previously diagnosed with 
epilepsy, 153 were included in the present study (3 had 
died, 3 had moved and 12 refused to participate). Be-
cause of missing data from the HAD, 22 depression items 
and 26 anxiety items were excluded post hoc from the 
analyses. The MINI was used to evaluate the 111 in-
dividuals who came to the hospital for the diagnostic 
interview.
The HAD identified 32 (24.4%) subjects as having de-
pression and 50 (39.4%) with an anxiety disorder. Being 
inactive (retired, unemployed or never had a job), fewer 
years of schooling and age above 41 years old were as-
sociated with depression. The female gender, fewer 
schooling years and being in the low economic group 
were associated with anxiety (Table 1). 
Specific epilepsy characteristics are presented in 
Table 2. Only active epilepsy was found to be associated 
with depression. Psychiatric comorbidities are presented 
in Table 3. Both anxiety and depression were identified 
in 21 individuals (42.9%). Lifetime suicidal thoughts and 
suicidal attempts were associated with both disorders, 
and lower scores on the GAS were associated with anx-
iety (Table 3).
DISCUSSION
Our findings indicated that individuals with epilepsy 
identified in a door-to-door survey have high frequen-
cies of anxiety (39.4%) and depression (24.4%). They also 
have important variables associated with both depression 
and anxiety, such as lower schooling, a higher risk of sui-
cidal behavior and the association of symptoms of both 
depression and anxiety. 
The major strengths of our study are its community 
setting, the use of validated psychometric scales and the 
fact that it was carried out in a developing country with 
the diagnosis of epilepsy being confirmed by neurolo-
gists. Nevertheless, some potential limitations should 
be considered. The size of our sample did not allow for 
multiple regression analysis, which would have identified 
discriminators that may predispose individuals for de-
pression and anxiety in epilepsy. Due to economic limi-
tations and because our sample was derived from a pre-
vious survey, we had a limited number of participants. 
The possible occurrence of a type I error should there-
fore be kept in mind. 
Other limitations of our study included interviewers 
who were not senior researchers and the lack of inter-
rater reliability assessments. The diagnoses of depressive 
or anxiety disorders made during the screening phase 
of the study were not later confirmed, as it was consid-
ered operationally difficult to obtain a reliable assessment 
by means of a standardized psychiatric interview. Struc-
tured psychiatric interviews are reliable and efficient; 
however, they require considerable time and are not 
readily accessible to standard practice in a non-psychi-
atric environment. A comprehensive review found that 
HAD performed well in assessing the symptom-severity 
and caseness of depression and anxiety in somatic, psy-
chiatric and primary care patients, as well as in the gen-
eral population19. This review reported an optimal bal-
ance between sensitivity and specificity when caseness 
was defined by a score of 8 or above on both the anxiety 
and depression subscales19.
The frequencies of depression (24.4%) and anxiety 
(39.4%) encountered in our study are higher than the fig-
ures from a Canadian population-based study (17.4 and 
22.8%, respectively)3. In contrast, they are lower when 
compared to those found in West Africa, where the re-
spective frequencies of depression and anxiety were 84 
and 66% in Togo and 85.3 and 84.1% in Benin12. Meth-
odological issues might have contributed to differences 
found, for example, in the questionnaires used to identify 
depression and anxiety. The Composite International Di-
agnostic Interview used in the Canadian study is a diag-
nostic interview for the assessment of mental disorders 
according to the definitions and criteria of the ICD-10 
and DSM-IV. As a diagnostic instrument, it is expected 
to generate more restrictive diagnosis categories20. On 
the other hand, the Goldberg’s Anxiety and Depression 
Scale used in Togo and Benin works best as a screening 
tool because of its high sensitivity (88-100%) and lower 
specificity (33-68%) to detect depression and anxiety21. 
The HAD applied in our sample is a screening tool de-
signed for detecting depression and anxiety in general 
medical settings and has been used in community studies 
of psychological outcome in epilepsy1,9,22. We adopted the 
cutoff points of the validation because it achieved 74% 
for both sensitivity and specificity for anxiety and 85.7 
and 72.4%, respectively, for depression14. Even though 
methodological issues might have contributed to the dif-
ferences, socio-economic and cultural factors may also 
have a role in the way people answered the questions. 
Epilepsy is associated with stigmatization and the “treat-
ment gap,” especially in developing countries, is likely one 
of the most important causes of non stabilized seizures, 
which is also connected to depression and anxiety23. 
Active epilepsy represented an almost 3-fold risk for 
depression. It has been suggested that recurrent seizures 
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OR† 95% CI‡ P value
Yes No
OR† 95% CI‡ P valueN % N % N % N %
Type of seizure 0.9 0.8
  Partial – simple 5 17.2 13 16.0 1.0 7 15.6 10 15.6 1.0
  Partial – complex 14 48.3 37 45.7 1.0 0.3-3.3 23 51.1 29 45.3 1.1 0.4-3.4
  Generalized 10 34.5 31 38.3 0.8 0.2-2.9 15 33.3 25 39.1 0.9 0.3-2.7
  Total 29 100 81 100 45 100 64 100
Age at first seizure 0.08 0.8
  ≤21 years 9 28.1 44 45.8 1.0 20 40.8 32 42.7 1.0
  >21 years 23 71.9 52 54.2 2.2 0.9-5.1 29 59.2 43 57.3 1.1 0.5-2.2
  Total 32 100 96 100 49 100 75 100
Active epilepsy 0.03 0.3
  No 9 30.0 49 53.3 1.0 20 42.5 37 52.1 1.0
  Yes 21 70.0 43 46.7 2.7 1.1-6.4 27 57.5 34 47.9 1.5 0.7-3.1




  Yes 28 87.5 77 77.8 2.0 0.6-6.3 39 78.0 62 80.5 0.86 0.4-2.1
  No 4 12.5 22 22.2 1.0 11 22.0 15 19.5 1.0
  Total 32 100 99 100 50 100 77 100
Antiepileptic treatment 0.8 0.3
  Monotherapy 18 75.0 39 78.0 1.0 19 73.1 38 82.6 1.0
  Polytherapy 6 25.0 11 22.0 1.2 0.4-3.7 7 26.9 8 17.4 1.7 0.5-5.5
  Total 24 100 50 100 26 100 46 100
Antiepileptic drugs 0.3 0.6
  Barbiturates 21 87.5 39 78.8 1.0 20 76.9 38 82.6 1.0
    No 3 12.5 11 22.0 0.5 0.1-2.0 6 23.1 8 17.4 1.4 0.4-4.7
    Yes 32 100 50 100 26 100 46 100
    Total
  Benzodiazepines 0.06 0.1
    No 20 83.3 48 96.0 1.0 22 84.6 44 95.6 1.0
    Yes 4 16.7 2 4.0 4.8 0.8-28.3 4 15.4 2 4.4 4.0 0.7-23.5
    Total 24 100 50 100 26 100 46 100
  Phenytoin 0.9 0.4
    No 19 79.2 40 80.0 1.0 22 84.6 35 76.1 1.0
    Yes 5 20.8 10 20.0 1.1 0.3-3.5 4 15.4 11 23.9 0.6 0.2-2.0
    Total 24 100 50 100 26 100 46 100
  Carbamazepine 0.8 0.6
    No 10 41.7 19 38.0 1.0 12 46.9 18 39.1 1.0
    Yes 14 58.3 31 62.0 0.9 0.3-2.3 14 53.8 28 60.9 0.7 0.3-2.0
    Total 24 100 50 100 26 100 46 100
  Valproate 0.9 0.9
    No 21 87.5 43 86.0 1.0 23 88.5 41 89.1 1.0
    Yes 3 12.5 7 14.0 0.9 0.2-3.7 3 11.5 5 10.9 1.1 0.2-4.9
    Total 24 100 50 100 26 100 46 100
†OR: crude odds ratio; ‡95% CI: 95% confidence interval.
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OR† 95% CI‡ P value
Yes No
OR† 95% CI‡ P valueN % N % N % N %
HAD§ Anxiety <0.0001
  Negative 10 32.3 66 70.2 1.0
  Positive 21 67.7 28 29.8 4.9 2.1-11.8
  Total 31 100 94 100
HAD§ Depression <0.0001
  Negative 28 57.1 66 86.8 1.0
  Positive 21 42.9 10 13.2 4.9 2.1-11.8
  Total 49 100 76 100
GAS¶ 0.04 0.01
  Mild (61-100) 22 68.7 81 85.3 1.0 34 69.4 65 87.8 1.0
  Moderate / 
  Severe (0-60)
10 31.3 14 14.7 2.6 1.0-6.7 15 30.6 9 12.2 3.2 1.3-8.0




  No 12 37.5 72 72.7 1.0 23 46.0 58 75.3 1.0
  Yes 20 62.5 27 27.3 4.4 1.9-10.3 27 54.0 19 24.7 3.6 1.7-7.7




  No 23 71.9 95 96.0 1.0 39 78.0 74 96.1 1.0
  Yes 9 28.1 4 4.0 9.3 2.6-32.8 11 22.0 3 3.9 6.9 1.8-26.4




1 4.8 31 48.4 1.0 03 9.7 28 52.8 1.0
  At least one 
  psychiatric diagnosis
20 95.2 33 51.6 18.8 2.4-148.5 28 90.3 25 47.2 10.4 2.8-38.6




  None 1 4.8 31 48.5 1.0 03 9.7 28 52.8 1.0
  1 10 47.6 21 32.8 14.8 1.7-124.1 13 41.9 18 34.0 6.7 1.7-27.0
  2 or more 10 47.6 12 18.7 25.8 2.9-224.2 15 48.4 7 13.2 20.0 4.5-88.8
  Total 21 100 64 100 31 100 53 100
†OR: crude odds ratio; ‡95% CI: 95% confidence interval; §HAD: Hospital Anxiety and Depression Scale; ¶GAS: Global Assessment Scale.
can be related to psychological sequela, and depression 
symptoms may influence the seizure frequency24,25. More 
recently, depression was thought to mediate the relation-
ship between stress and anxiety and changes in seizure 
frequency26.
Consistent with the literature regarding suicide, this 
behavior was increased among those with depression and 
those with anxiety disorder27. Depression is well known 
to pose a risk on suicidal behavior28, as well as anxiety 
disorders27,29. Moreover, there is an increasing relation-
ship between the number of mental disorders and sui-
cidal behavior29. Our findings also indicate an increased 
risk of depression and anxiety between people with ep-
ilepsy suffering from more than one psychiatric disease. 
In a systematic review, lower socio-economic status 
was associated with higher rates of depressed mood and 
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anxiety in youths30. Consistent with this result, individ-
uals in the lowest economic group in our sample had at 
least four times the risk of anxiety, and subjects with less 
than four years of schooling had a higher risk of both de-
pression and anxiety. These results are consistent with 
studies regarding depression and educational attain-
ment31,32. Lower educational levels may lead to an accu-
mulation of poor health outcomes associated with de-
pression among people with in a lower social class, which 
is consistent with a review of socioeconomic factors and 
cardiovascular disease in the population33. They may also 
lack the necessary resources (social or financial) to cope 
with depression when it occurs34.
While it is necessary to improve the recognition and 
treatment of depression and anxiety in people with ep-
ilepsy, it is also important to face other changeable fac-
tors associated with mental suffering, especially in devel-
oping countries, such as socio-economic conditions and 
adequate treatment of epilepsy.
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